批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2020/08/21 |
SUPPL-82(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/11/02 |
SUPPL-77(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/12/15 |
SUPPL-73(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2014/09/19 |
SUPPL-72(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2013/07/30 |
SUPPL-71(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2012/01/30 |
SUPPL-70(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/02/19 |
SUPPL-69(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2005/10/30 |
SUPPL-61(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/01/31 |
SUPPL-53(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1999/03/11 |
SUPPL-52(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/03/11 |
SUPPL-51(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/03/11 |
SUPPL-48(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/03/11 |
SUPPL-46(补充) |
Approval |
Labeling |
|
|
|
1997/04/09 |
SUPPL-50(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1993/01/25 |
SUPPL-47(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1991/08/08 |
SUPPL-45(补充) |
Approval |
Labeling |
|
|
|
1991/02/06 |
SUPPL-44(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1991/02/06 |
SUPPL-43(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1988/04/27 |
SUPPL-42(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1987/09/15 |
SUPPL-40(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1987/07/13 |
SUPPL-41(补充) |
Approval |
Labeling |
|
|
|
1987/01/27 |
SUPPL-39(补充) |
Approval |
Labeling |
|
|
|
1987/01/27 |
SUPPL-38(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1985/09/11 |
SUPPL-35(补充) |
Approval |
Labeling |
|
|
|
1985/08/24 |
SUPPL-37(补充) |
Approval |
Labeling |
|
|
|
1985/08/19 |
SUPPL-36(补充) |
Approval |
Labeling |
|
|
|
1985/05/20 |
SUPPL-31(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1984/03/02 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1983/12/01 |
SUPPL-34(补充) |
Approval |
Labeling |
|
|
|
1983/11/21 |
SUPPL-24(补充) |
Approval |
Labeling |
|
|
|
1983/07/13 |
SUPPL-29(补充) |
Approval |
Labeling |
|
|
|
1983/07/13 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1983/01/21 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1982/01/27 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1981/12/28 |
SUPPL-23(补充) |
Approval |
Labeling |
|
|
|
1981/08/21 |
SUPPL-22(补充) |
Approval |
Labeling |
|
|
|
1981/08/21 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1980/11/03 |
SUPPL-19(补充) |
Approval |
Labeling |
|
|
|
1980/08/21 |
SUPPL-15(补充) |
Approval |
Labeling |
|
|
|
1980/08/21 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1979/12/06 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1979/06/18 |
SUPPL-17(补充) |
Approval |
Labeling |
|
|
|
1979/04/04 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1979/04/04 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1978/06/15 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1978/06/15 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1976/11/30 |
SUPPL-7(补充) |
Approval |
Labeling |
|
|
|
1976/07/07 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1976/06/10 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1976/06/10 |
SUPPL-4(补充) |
Approval |
Labeling |
|
|
|
1976/06/07 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1976/01/13 |
SUPPL-3(补充) |
Approval |
Labeling |
|
|
|
1972/10/03 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:BUPIVACAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.25% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
016964 |
001 |
NDA |
MARCAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
016964 |
012 |
NDA |
MARCAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
018304 |
001 |
NDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
Yes |
No |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
070552 |
001 |
ANDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
1986/05/21
|
FRESENIUS KABI USA |
070583 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
1987/02/17
|
HOSPIRA |
070590 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
1987/02/17
|
HOSPIRA |
091487 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2011/10/18
|
STERISCIENCE SPECLTS |
091503 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2011/10/18
|
STERISCIENCE SPECLTS |
203895 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2013/11/05
|
EUGIA PHARMA |
207183 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2016/05/13
|
EUGIA PHARMA |
204842 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2021/02/11
|
HIKMA PHARMS |
205141 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2021/02/11
|
HIKMA PHARMS |
216039 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2023/06/23
|
MEITHEAL |
217792 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2023/11/20
|
SOMERSET |
216040 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2023/12/27
|
MEITHEAL |
217821 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2024/03/27
|
ASPIRO |
活性成分:BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.25%;0.0091MG/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
016964 |
004 |
NDA |
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.25%;0.0091MG/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
016964 |
013 |
NDA |
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.25%;0.0091MG/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
070966 |
001 |
ANDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.25%;0.0091MG/ML |
Prescription |
No |
No |
AP |
1987/10/13
|
FRESENIUS KABI USA |
070967 |
001 |
ANDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.25%;0.0091MG/ML |
Prescription |
No |
No |
AP |
1987/10/13
|
FRESENIUS KABI USA |
活性成分:BUPIVACAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.5% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
016964 |
005 |
NDA |
MARCAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
016964 |
006 |
NDA |
MARCAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
018304 |
002 |
NDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
Yes |
No |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
070584 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
1986/02/17
|
HOSPIRA |
070553 |
001 |
ANDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
1986/05/21
|
FRESENIUS KABI USA |
070597 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
1987/03/03
|
HOSPIRA |
070609 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
1987/03/03
|
HOSPIRA |
091487 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2011/10/18
|
STERISCIENCE SPECLTS |
091503 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2011/10/18
|
STERISCIENCE SPECLTS |
203895 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2013/11/05
|
EUGIA PHARMA |
207183 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2016/05/13
|
EUGIA PHARMA |
204842 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2021/02/11
|
HIKMA PHARMS |
205141 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2021/02/11
|
HIKMA PHARMS |
216039 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2023/06/23
|
MEITHEAL |
217792 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2023/11/20
|
SOMERSET |
216040 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2023/12/27
|
MEITHEAL |
217821 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2024/03/27
|
ASPIRO |
活性成分:BUPIVACAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.5% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
016964 |
005 |
NDA |
MARCAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
016964 |
006 |
NDA |
MARCAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
018304 |
002 |
NDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
Yes |
No |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
070584 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
1986/02/17
|
HOSPIRA |
070553 |
001 |
ANDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
1986/05/21
|
FRESENIUS KABI USA |
070597 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
1987/03/03
|
HOSPIRA |
070609 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
1987/03/03
|
HOSPIRA |
091487 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2011/10/18
|
STERISCIENCE SPECLTS |
091503 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2011/10/18
|
STERISCIENCE SPECLTS |
203895 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2013/11/05
|
EUGIA PHARMA |
207183 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2016/05/13
|
EUGIA PHARMA |
204842 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2021/02/11
|
HIKMA PHARMS |
205141 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2021/02/11
|
HIKMA PHARMS |
216039 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2023/06/23
|
MEITHEAL |
217792 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2023/11/20
|
SOMERSET |
216040 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2023/12/27
|
MEITHEAL |
217821 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
2024/03/27
|
ASPIRO |
活性成分:BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.5%;0.0091MG/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
016964 |
007 |
NDA |
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.5%;0.0091MG/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
016964 |
008 |
NDA |
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.5%;0.0091MG/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
018304 |
004 |
NDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.5%;0.0091MG/ML |
Prescription |
Yes |
No |
AP |
1983/09/02
|
FRESENIUS KABI USA |
070968 |
001 |
ANDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.5%;0.0091MG/ML |
Prescription |
No |
No |
AP |
1987/10/13
|
FRESENIUS KABI USA |
活性成分:BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.5%;0.0091MG/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
016964 |
007 |
NDA |
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.5%;0.0091MG/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
016964 |
008 |
NDA |
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.5%;0.0091MG/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
018304 |
004 |
NDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.5%;0.0091MG/ML |
Prescription |
Yes |
No |
AP |
1983/09/02
|
FRESENIUS KABI USA |
070968 |
001 |
ANDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.5%;0.0091MG/ML |
Prescription |
No |
No |
AP |
1987/10/13
|
FRESENIUS KABI USA |
活性成分:BUPIVACAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.75% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
016964 |
009 |
NDA |
MARCAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.75% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
018304 |
003 |
NDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.75% |
Prescription |
Yes |
No |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
070554 |
001 |
ANDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.75% |
Prescription |
No |
No |
AP |
1986/05/21
|
FRESENIUS KABI USA |
070585 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.75% |
Prescription |
No |
No |
AP |
1987/03/03
|
HOSPIRA |
091487 |
003 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.75% |
Prescription |
No |
No |
AP |
2011/10/18
|
STERISCIENCE SPECLTS |
203895 |
003 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.75% |
Prescription |
No |
No |
AP |
2013/11/05
|
EUGIA PHARMA |
204842 |
003 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.75% |
Prescription |
No |
No |
AP |
2021/02/11
|
HIKMA PHARMS |
216040 |
003 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.75% |
Prescription |
No |
No |
AP |
2023/12/27
|
MEITHEAL |
217821 |
003 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.75% |
Prescription |
No |
No |
AP |
2024/03/27
|
ASPIRO |
活性成分:BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.75%;0.0091MG/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
016964 |
010 |
NDA |
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.75%;0.0091MG/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
018304 |
005 |
NDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.75%;0.0091MG/ML |
Prescription |
Yes |
No |
AP |
1983/09/02
|
FRESENIUS KABI USA |
活性成分:BUPIVACAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.25% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
016964 |
001 |
NDA |
MARCAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
016964 |
012 |
NDA |
MARCAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
018304 |
001 |
NDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
Yes |
No |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
070552 |
001 |
ANDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
1986/05/21
|
FRESENIUS KABI USA |
070583 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
1987/02/17
|
HOSPIRA |
070590 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
1987/02/17
|
HOSPIRA |
091487 |
002 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2011/10/18
|
STERISCIENCE SPECLTS |
091503 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2011/10/18
|
STERISCIENCE SPECLTS |
203895 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2013/11/05
|
EUGIA PHARMA |
207183 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2016/05/13
|
EUGIA PHARMA |
204842 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2021/02/11
|
HIKMA PHARMS |
205141 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2021/02/11
|
HIKMA PHARMS |
216039 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2023/06/23
|
MEITHEAL |
217792 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2023/11/20
|
SOMERSET |
216040 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2023/12/27
|
MEITHEAL |
217821 |
001 |
ANDA |
BUPIVACAINE HYDROCHLORIDE |
BUPIVACAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.25% |
Prescription |
No |
No |
AP |
2024/03/27
|
ASPIRO |
活性成分:BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.25%;0.0091MG/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
016964 |
004 |
NDA |
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.25%;0.0091MG/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
016964 |
013 |
NDA |
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.25%;0.0091MG/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
070966 |
001 |
ANDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.25%;0.0091MG/ML |
Prescription |
No |
No |
AP |
1987/10/13
|
FRESENIUS KABI USA |
070967 |
001 |
ANDA |
SENSORCAINE |
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
0.25%;0.0091MG/ML |
Prescription |
No |
No |
AP |
1987/10/13
|
FRESENIUS KABI USA |